Company Profile

Ferrologix Inc
Profile last edited on: 9/7/22      CAGE: 7DWK5      UEI: DQQNJMSHXEQ6

Business Identifier: Magnetic nanotechnology to accelerate research and manufacturing of cellular therapies
Year Founded
2015
First Award
2017
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

23328 Barfield Drive
Valencia, CA 91354
   (760) 533-2826
   ttiemann@ferrologix.com
   www.ferrologix.com
Location: Single
Congr. District: 33
County: Los Angeles

Public Profile

With cell purification a critical need in development and production of cutting edge diagnostics and therapeutics, Ferrologix is structured around a unique magnetic-based instrument & disposable cartridge that can transport, filter, and organize single cells for precision analysis or therapeutic manufacture. Anchored in a new technique - designated Digital Magnetic Sorting (aka Ratcheting Cytometry) - Ferrologix is developing a suite of tools to assist, accelerate, and scale the development of precision medicine research, next gen diagnostics, and cellular therapies. That core capability involves employing an array of inexpensive magnetic micropillars patterned onto a plastic substrate to form a single use cartridge. When subjected to a rotating magnetic field cells which have been labeled with a magnetic antibody can be precisely manipulated in a massively parallelized format. Various chip designs can execute a variety of functions such as rapid cell purification, quantitative separation based on surface expression, and cell co-localization with transduction/transfection reagents. Advantages: Quick: 10X faster than current magnetic purification platforms; Quantitative: Separate specific cell subtypes; Closed: Aseptic operation to meet GMP standards and Continuous: Compatible with large volumes and cell quantities

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Key People / Management

  Tim Tiemann -- CEO

  Savannah Bshara-Corson -- Director of Bioassay Development/Senior Scientist

  Dino Di Carlo -- Advisor

  Coleman Murray -- COO

Company News

There are no news available.